《JAMA,3月28日,Sourcing Personal Protective Equipment During the COVID-19 Pandemic》

  • 来源专题:COVID-19科研动态监测
  • 编译者: zhangmin
  • 发布时间:2020-03-29
  • Sourcing Personal Protective Equipment During the COVID-19 Pandemic

    Edward Livingston, MD1; Angel Desai, MD, MPH1; Michael Berkwits, MD, MSCE1

    Author Affiliations Article Information

    JAMA. Published online March 28, 2020. doi:10.1001/jama.2020.5317

    As the coronavirus disease 2019 (COVID-19) pandemic accelerates, global health care systems have become overwhelmed with potentially infectious patients seeking testing and care. Preventing spread of infection to and from health care workers (HCWs) and patients relies on effective use of personal protective equipment (PPE)—gloves, face masks, air-purifying respirators, goggles, face shields, respirators, and gowns. A critical shortage of all of these is projected to develop or has already developed in areas of high demand. PPE, formerly ubiquitous and disposable in the hospital environment, is now a scarce and precious commodity in many locations when it is needed most to care for highly infectious patients. An increase in PPE supply in response to this new demand will require a large increase in PPE manufacturing, a process that will take time many health care systems do not have, given the rapid increase in ill COVID-19 patients.

  • 原文来源:https://jamanetwork.com/journals/jama/fullarticle/2764031?resultClick=1
相关报告
  • 《NEJM,3月25日,Critical Supply Shortages — The Need for Ventilators and Personal Protective Equipment during the Covid-19 Pandemic》

    • 来源专题:COVID-19科研动态监测
    • 编译者:xuwenwhlib
    • 发布时间:2020-03-26
    • Critical Supply Shortages — The Need for Ventilators and Personal Protective Equipment during the Covid-19 Pandemic List of authors. Megan L. Ranney, M.D., M.P.H., Valerie Griffeth, M.D., Ph.D., and Ashish K. Jha, M.D., M.P.H. March 25, 2020 DOI: 10.1056/NEJMp2006141 On March 11, 2020, the World Health Organization designated “coronavirus disease 2019” (Covid-19) a global pandemic. As the number of cases in the United States continues to grow, political leaders are encouraging physical (or “social”) distancing to slow the rate of transmission. The goal of this practice is to flatten the curve of new infection, thereby avoiding a surge of demand on the health care system, but the effects of physical distancing may take weeks to appear. U.S. hospitals are already reporting shortages of key equipment needed to care for critically ill patients, including ventilators and personal protective equipment (PPE) for medical staff. Adequate production and distribution of both types of equipment are crucial to caring for patients during the pandemic.
  • 《JAMA,5月28日,Prescription Fill Patterns for Commonly Used Drugs During the COVID-19 Pandemic in the United States》

    • 来源专题:COVID-19科研动态监测
    • 编译者:xuwenwhlib
    • 发布时间:2020-05-29
    • Prescription Fill Patterns for Commonly Used Drugs During the COVID-19 Pandemic in the United States Muthiah Vaduganathan, MD, MPH1; Jeroen van Meijgaard, PhD2; Mandeep R. Mehra, MD, MSc1; et alJacob Joseph, MD3; Christopher J. O’Donnell, MD, MPH3; Haider J. Warraich, MD3 Author Affiliations Article Information JAMA. Published online May 28, 2020. doi:10.1001/jama.2020.9184 Conflicting information regarding the benefits of hydroxychloroquine/chloroquine and azithromycin in coronavirus disease 2019 (COVID-19) treatment and hypothetical concerns for drugs, such as angiotensin-converting enzyme (ACE) inhibitors and angiotensin receptor blockers (ARBs), have challenged care during the pandemic.1 However, limited data are available about how prescription of these therapies has changed. The objective of this exploratory analysis was to evaluate prescription patterns of these therapies, along with other commonly used drugs for reference, in the United States during the COVID-19 pandemic. We hypothesized that the prescription of hydroxychloroquine/chloroquine and azithromycin would exceed historical estimates while ACE inhibitor/ARB use would be reduced.